Showing results (721-730 of 2,281) with videos related to

Sort By:
Pageof 229
HIV Medicine|March 30, 2010
Analysis of serious non-AIDS events among HIV-infected adults at Latin American sitesW H Belloso, L C Orellana, B Grinsztejn, et al.
HIV Medicine|March 30, 2010
Measures of site resourcing predict virologic suppression, immunologic response and HIV disease progression following highly active antiretroviral therapy (HAART) in the TREAT Asia HIV Observational Database (TAHOD)R Oyomopito, M P Lee, P Phanuphak, et al.
HIV Medicine|March 30, 2010
Effect of simplification from protease inhibitors to boosted atazanavir-based regimens in real-life conditionsR Rubio, O Serrano, J Carmena, et al.
HIV Medicine|March 30, 2010
Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baselineM C Hosseinipour, J J Kumwenda, R Weigel, et al.
HIV Medicine|August 30, 2008
Routine, voluntary HIV testing in Durban, South Africa: correlates of HIV infectionI V Bassett, J Giddy, B Wang, et al.
HIV Medicine|August 30, 2008
Stability of HIV RNA in plasma specimens stored at different temperaturesB Amellal, R Murphy, A Maiga, et al.
HIV Medicine|July 18, 2008
The relationship between ApoE, TNFA, IL1a, IL1b and IL12b genes and HIV-1-associated dementiaL A Pemberton, E Stone, P Price, et al.
HIV Medicine|July 18, 2008
Prediction of phenotypic susceptibility to antiretroviral drugs using physiochemical properties of the primary enzymatic structure combined with artificial neural networksJ Kjaer, L Høj, Z Fox, et al.
HIV Medicine|August 15, 2006
Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudineF van Leth, D B Hall, J M A Lange, et al.
HIV Medicine|August 15, 2006
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyT R Glass, C Ungsedhapand, M Wolbers, et al.
Pageof 229